Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Crotty currently holds 41,194 shares of Nabriva Therapeutics plc (NBRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Crotty has been a net buyer of NBRV stock. They have purchased $44.8K and sold $9.6K worth of shares.
Robert Crotty's most recent insider trade was on Aug 31, 2021, when they sold 37 shares at $1.06 per share.
Robert Crotty serves as Executive at Nabriva Therapeutics plc (NBRV). They have executed 45 insider transactions totaling $54.4K over their tenure at the company.
Robert Crotty holds the position of Executive at Nabriva Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Robert Crotty has shown a buying trading pattern, with $44.8K in total purchases and $9.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert Crotty was on May 23, 2018, when they purchased $44.8K worth of NBRV shares. This transaction involved 10,000 shares at $4.48 per share.
Robert Crotty currently owns 41,194 shares of Nabriva Therapeutics plc (NBRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Crotty's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Crotty has 45 Form 4 filings on record as an insider at Nabriva Therapeutics plc.
Set alerts for Robert Crotty and 40,000+ other insiders.